Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DEVLIES PHARMA from Kortrijk, company number BE0877804765, closed financial year 2025 with a result of € -13,894 after tax. For that financial year DEVLIES PHARMA recorded a gross margin of € 126,931 and equity of € 149,857. Compared with financial year 2024, the result moved from € 5,533 to € -13,894. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on December 15, 2025.
€ 149,857
▼ 8% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,894
▼ still € 5,533 profit in 2024
Profit after tax over the fiscal year.
€ 26,833
▲ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -30,143.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 61,055
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,341
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 394,063
€ 123,562 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 125,087
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,751
▼ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 126,878 | € 128,864 | € 151,895 | € 126,931 | ▼ 16% |
| Profit after taxes | € 435 | € 656 | € 5,533 | € -13,894 | ▼ € 19,427 |
| Equity | € 157,562 | € 158,217 | € 163,750 | € 149,857 | ▼ 8% |
| Total debts | € 622,037 | € 602,488 | € 553,802 | € 525,785 | ▼ 5% |
| Cash | € 21,091 | € 18,563 | € 21,104 | € 26,833 | ▲ 27% |
| Land & buildings | € 397,930 | € 375,501 | € 353,072 | € 330,642 | ▼ 6% |
| Retained profit | € -22,438 | € -21,783 | € -16,250 | € -30,143 | ▼ € 13,894 |
| Bank debt | € 486,067 | € 440,221 | € 394,222 | € 394,063 | |
| Balance sheet total | € 779,599 | € 760,706 | € 717,552 | € 675,641 | ▼ 6% |
| Employees (FTE) | 0.8 | 0.8 | 0.8 | 0.8 |
Key figures of DEVLIES PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DEVLIES PHARMA?
What happened at DEVLIES PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 13,894 (▼ € 19,427 vs 2024). Source: NBB ↗
- DPH bv became a director. NBB
- DEVLIES EN PARTNERS bv became a director. NBB
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
In short
From € 435 profit in 2022 to € 13,894 loss in 2025.
Paid € 254 in corporate taxes since 2022.
Best year ever: 2024, with € 5,533 profit.
A new publication or filing at DEVLIES PHARMA? We notify you, reason included.
Follow DEVLIES PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DEVLIES PHARMA are DEVLIES EN PARTNERS bv and DPH bv.
Directors
According to the 2025 annual accounts
Director · represented by Devlies JACQUES
since 2022
Director · represented by Devlies PATRICIA
since 2022
Establishments
Establishment units
Physical locations of this company
Moeskroensesteenweg(Aal) 81
8511 Kortrijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
UPCLOUD, FI
Website info
Features
Security
Details
- Company number
- 0877.804.765
- VAT number
- BE 0877.804.765
- Registered office
- Moeskroensesteenweg(Aal) 81, 8511 Kortrijk
- Names & denominations
- DEVLIES PHARMA · D PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 December 2005
- Peppol
- Active · Active since 29 Dec 2025
- Contact
- apotheekdpharma.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Vervaardiging van overige farmaceutische producten
Activiteiten van medische beeldvorming en medische laboratoria
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Medische laboratoria
Detailhandel in medische en orthopedische artikelen
+3